sj-docx-1-tab-10.1177_1759720X211067304 ��� Supplemental material for Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study

Autor: Tang, Honghu, Cui, Beibei, Chen, Yiyu, Chen, Lin, Wang, Zhihong, Zhang, Ning, Yang, Yanlan, Wang, Xiaodong, Xie, Xiangliang, Sun, Lingyun, Dang, Wantai, Wang, Xianyang, Li, Runzi, Zou, Jianjun, Zhao, Yi, Liu, Yi
Rok vydání: 2022
Předmět:
ISSN: 1759-720X
DOI: 10.25384/sage.19100463
Popis: Supplemental material, sj-docx-1-tab-10.1177_1759720X211067304 for Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study by Honghu Tang, Beibei Cui, Yiyu Chen, Lin Chen, Zhihong Wang, Ning Zhang, Yanlan Yang, Xiaodong Wang, Xiangliang Xie, Lingyun Sun, Wantai Dang, Xianyang Wang, Runzi Li, Jianjun Zou, Yi Zhao and Yi Liu in Therapeutic Advances in Musculoskeletal Disease
Databáze: OpenAIRE